ALPHA | Overview of Technology◾️What is SciTech at Abbott LaboratoriesA suite of technologies to measure, judge, and ...

Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated ...

Dexcom DXCM recently released its 2026 “State of Type 2 Report: Global Access and Attitudes to Diabetes Technology” ahead of the 62nd Annual Meeting of the European Association for the Study of ...

Abbott (NYSE:ABT) has secured FDA approval for CardioMEMS HF System updates, enabling heart-pressure tracking and custom ...

Tandem Diabetes Care has recently launched its Tandem Mobi automated insulin delivery system in 12 countries across Europe ...

Tandem Mobi is powered by Control-IQ+ technology, the predictive algorithm that automates insulin delivery. The system uses a Dexcom G7 continuous glucose monitoring system to predict glucose levels ...

Nice to meet you. I am Rei Hattori, the director of Hattori Clinic Chiryu, a clinic specializing in diabetes, thyroid, and ...

Adults with Type 2 diabetes using a continuous glucose monitoring (CGM) system, including Libre technology, had a 45% lower risk of death at 12 months and a 36% lower risk at 24 months compared with ...

The last 12 months at Abbott Laboratories (NYSE:ABT) has been defined by a bold bet that put at risk the reputation it has carried for decades as a medtech ...

Continuous glucose monitors strapped to competitive endurance athletes have revealed something striking: when the starting ...

Beta Bionics, Inc. ( BBNX) announced FDA clearance of Mint, its new patch pump featuring a reusable and disposable architecture, while unveiling 3D Intelligence, its next-generation insulin dosing ...

Erik Lofstrand never expected a routine physical to change his life. But when he was diagnosed with Type 2 diabetes, Erik ...